{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T19:48:20Z","timestamp":1767383300872},"reference-count":36,"publisher":"Japan Atherosclerosis Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5551\/jat.12526","type":"journal-article","created":{"date-parts":[[2012,7,10]],"date-time":"2012-07-10T23:25:18Z","timestamp":1341962718000},"page":"837-845","source":"Crossref","is-referenced-by-count":28,"title":["Different Distribution of Pentraxin 3 and C-Reactive Protein in Coronary Atherosclerotic Plaques"],"prefix":"10.5551","volume":"19","author":[{"given":"Yunosuke","family":"Matsuura","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Miyazaki."},{"name":"Department of Pathology, Faculty of Medicine, University of Miyazaki."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinta","family":"Hatakeyama","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, University of Miyazaki."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuroh","family":"Imamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Miyazaki."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Tsuruda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Miyazaki."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshisato","family":"Shibata","sequence":"additional","affiliation":[{"name":"Miyazaki Medical Association Hospital."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiko","family":"Kodama","sequence":"additional","affiliation":[{"name":"Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Miyazaki."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiro","family":"Asada","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, University of Miyazaki."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Libby P: Inflammation in atherosclerosis. Nature, 2002; 420: 868-874","DOI":"10.1038\/nature01323"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Libby P, Ridker PM, Hansson GK: Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol, 2009; 54: 2129-2138","DOI":"10.1016\/j.jacc.2009.09.009"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Corrado E, Rizzo M, Coppola G, Fattouch K, Novo G, Marturana I, Ferrara F, Novo S: An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb, 2010; 17: 1-11","DOI":"10.5551\/jat.2600"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Homma Y: Predictors of atherosclerosis. J Atheroscler Thromb, 2004; 11: 265-270","DOI":"10.5551\/jat.11.265"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Anand SS, Razak F, Yi Q, Davis B, Jacobs R, Vuksan V, Lonn E, Teo K, McQueen M, Yusuf S: C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol, 2004; 24: 1509-1515","DOI":"10.1161\/01.ATV.0000135845.95890.4e"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Buckley DI, Fu R, Freeman M, Rogers K, Helfand M: C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med, 2009; 151: 483-495","DOI":"10.7326\/0003-4819-151-7-200910060-00009"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ray KK, Cannon CP, Cairns R, Morrow DA, Ridker PM, Braunwald E: Prognostic utility of apoB\/AI, total cholesterol\/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE ITTIMI 22. Arterioscler Thromb Vasc Biol, 2009; 29: 424-430","DOI":"10.1161\/ATVBAHA.108.181735"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators: C-reactive protein levels and outcomes after statin therapy. N Engl J Med, 2005; 352: 20-28","DOI":"10.1056\/NEJMoa042378"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ferreir&oacute;s ER, Boissonnet CP, Pizarro R, Merletti PF, Corrado G, Cagide A, Bazzino OO: Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation, 1999; 100: 1958-1963","DOI":"10.1161\/01.CIR.100.19.1958"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Castell JV, G&oacute;mez-Lech&oacute;n MJ, David M, Fabra R, Trullenque R, Heinrich PC: Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology, 1990; 12: 1179-1186","DOI":"10.1002\/hep.1840120517"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Presta M, Camozzi M, Salvatori G, Rusnati M: Role of the soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med, 2007; 11: 723-738","DOI":"10.1111\/j.1582-4934.2007.00061.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Mantovani A, Garlanda C, Doni A, Bottazzi B: Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol, 2008; 28: 1-13","DOI":"10.1007\/s10875-007-9126-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, Sagara M, Miyamoto K, Satoh H, Kohno I, Kurata T, Ota H, Mantovani A, Hamakubo T, Daida H, Kodama T: Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol, 2007; 27: 161-167","DOI":"10.1161\/01.ATV.0000252126.48375.d5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, Vago L, Pasqualini F, Signorini S, Soldateschi D, Tarli L, Schweiger C, Fresco C, Cecere R, Tognoni G, Mantovani A; Lipid Assessment Trial Italian Network (LATIN) Investigators: Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation, 2004; 110: 2349-2354","DOI":"10.1161\/01.CIR.0000145167.30987.2E"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Jenny NS, Arnold AM, Kuller LH, Tracy RP, Psaty BM: Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol, 2009; 29: 594-599","DOI":"10.1161\/ATVBAHA.108.178947"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Sun H, Koike T, Ichikawa T, Hatakeyama K, Shiomi M, Zhang B, Kitajima S, Morimoto M, Watanabe T, Asada Y, Chen YE, Fan J: C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol, 2005; 167: 1139-1148","DOI":"10.1016\/S0002-9440(10)61202-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Rolph MS, Zimmer S, Bottazzi B, Garlanda C, Mantovani A, Hansson GK: Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler Thromb Vasc Biol, 2002; 22: e10-e14","DOI":"10.1161\/01.ATV.0000015595.95497.2F"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Savchenko A, Imamura M, Ohashi R, Jiang S, Kawasaki T, Hasegawa G, Emura I, Iwanari H, Sagara M, Tanaka T, Hamakubo T, Kodama T, Naito M: Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J Pathol, 2008; 215: 48-55","DOI":"10.1002\/path.2314"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ishikawa T, Hatakeyama K, Imamura T, Date H, Shibata Y, Hikichi Y, Asada Y, Eto T: Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris. Am J Cardiol, 2003; 91: 287-292","DOI":"10.1016\/S0002-9149(02)03156-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Sato Y, Hatakeyama K, Yamashita A, Marutsuka K, Sumiyoshi A, Asada Y: Proportion of fibrin and platelets differs in thrombi on ruptured and eroded coronary atherosclerotic plaques in humans. Heart, 2005; 91: 526-530","DOI":"10.1136\/hrt.2004.034058"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb, 1994; 14: 840-856","DOI":"10.1161\/01.ATV.14.5.840"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol, 1995; 15: 1512-1531","DOI":"10.1161\/01.ATV.15.9.1512"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Nishihira K, Imamura T, Yamashita A, Hatakeyama K, Shibata Y, Nagatomo Y, Date H, Kita T, Eto T, Asada Y: Increased expression of interleukin-10 in unstable plaque obtained by directional coronary atherectomy. Eur Heart J, 2006; 27: 1685-1689","DOI":"10.1093\/eurheartj\/ehl058"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Solem J, Levin M, Karlsson T, Grip L, Albertsson P, Wiklund O: Composition of coronary plaques obtained by directional atherectomy in stable angina: its relation to serum lipids and statin treatment. J Intern Med, 2006; 259: 267-275","DOI":"10.1111\/j.1365-2796.2006.01608.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Garlanda C, Bottazzi B, Bastone A, Mantovani A: Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol, 2005; 23: 337-366","DOI":"10.1146\/annurev.immunol.23.021704.115756"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Bottazzi B, Bastone A, Doni A, Garlanda C, Valentino S, Deban L, Maina V, Cotena A, Moalli F, Vago L, Salustri A, Romani L, Mantovani A: The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility. J Leukoc Biol, 2006; 79: 909-912","DOI":"10.1189\/jlb.1005557"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) van Rossum AP, Pas HH, Fazzini F, Huitema MG, Limburg PC, Jonkman MF, Kallenberg CG: Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis. Arthritis Rheum, 2006; 54: 986-991","DOI":"10.1002\/art.21669"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Maina V, Cotena A, Doni A, Nebuloni M, Pasqualini F, Milner CM, Day AJ, Mantovani A, Garlanda C: Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6. J Leukoc Biol, 2009; 86: 123-132","DOI":"10.1189\/jlb.0608345"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Graversen JH, Madsen M, Moestrup SK: CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int J Biochem Cell Biol, 2002; 34: 309-314","DOI":"10.1016\/S1357-2725(01)00144-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Yunoki K, Naruko T, Komatsu R, Ehara S, Shirai N, Sugioka K, Nakagawa M, Kitabayashi C, Ikura Y, Itoh A, Kusano K, Ohe T, Haze K, Becker AE, Ueda M: Enhanced expression of haemoglobin scavenger receptor in accumulated macrophages of culprit lesions in acute coronary syndromes. Eur Heart J, 2009; 30: 1844-1852","DOI":"10.1093\/eurheartj\/ehp257"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Boyle JJ, Harrington HA, Piper E, Elderfield K, Stark J, Landis RC, Haskard DO: Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am J Pathol, 2009; 174: 1097-1108","DOI":"10.2353\/ajpath.2009.080431"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Doni A, Michela M, Bottazzi B, Peri G, Valentino S, Polentarutti N, Garlanda C, Mantovani A: Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma. J Leukoc Biol, 2006; 79: 797-802","DOI":"10.1189\/jlb.0905493"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Polentarutti N, Picardi G, Basile A, Cenzuales S, Rivolta A, Matteucci C, Peri G, Mantovani A, Introna M: Interferon-gamma inhibits expression of the long pentraxin PTX3 in human monocytes. Eur J Immunol, 1998; 28: 496-501","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<496::AID-IMMU496>3.0.CO;2-V"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Van Vr&eacute; EA, Bult H, Hoymans VY, Van Tendeloo VF, Vrints CJ, Bosmans JM: Human C-reactive protein activates monocyte-derived dendritic cells and induces dendritic cell-mediated T-cell activation. Arterioscler Thromb Vasc Biol, 2008; 28: 511-518","DOI":"10.1161\/ATVBAHA.107.157016"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Devaraj S, Jialal I. C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype. Arterioscler Thromb Vasc Biol, 2011; 31: 1397-1402","DOI":"10.1161\/ATVBAHA.111.225508"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Norata GD, Marchesi P, Pulakazhi Venu VK, Pasqualini F, Anselmo A, Moalli F, Pizzitola I, Garlanda C, Mantovani A, Catapano AL: Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation, 2009; 120: 699-708","DOI":"10.1161\/CIRCULATIONAHA.108.806547"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/19\/9\/19_12526\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T21:11:50Z","timestamp":1497993110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/19\/9\/19_12526\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.12526","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}